Once-weekly CagriSema significantly reduced HbA1c and body weight vs semaglutide in patients with type 2 diabetes in the REIMAGINE 2 trial.

A review of notable updates that occurred in January 2026 for investigational products in development (not an inclusive list).

Review finds no evidence supporting CDC changes to newborn hepatitis B vaccine guidelines; universal birth dose remains the safest strategy.

Obesity is associated with widespread metabolic remodeling involving lipoproteins, fatty acids, amino acids, and inflammation ...

The AMA joined the ASPS in recommending that gender-related surgical procedures be deferred until patients reach adulthood.

Cessation of weight management medications (WMMs) is followed by weight regain and cardiometabolic marker deterioration.

The new TrumpRx website offers discounts on drug prices via coupons, but existing provider co-pays may offer lower prices.

Partial hepatectomy is linked to an increased risk for postoperative myocardial injury vs other major abdominal operations.

The FDA accepted the New Drug Application for zanzalintinib plus atezolizumab for the treatment of adult patients with metastatic colorectal cancer.

Higher perimenopausal fasting insulin and body mass index were associated with the onset and length of hot flashes and night sweats.

Hims & Hers withdrew its pill which was a knockoff version of Novo Nordisk's oral Wegovy after a referral to the Justice Department.

Women with higher adherence to the Mediterranean diet had a lower risk for stroke for all stroke, ischemic, and hemorrhagic subtypes.